Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes - NCT01004848-10029 (Clinical Trial 385940)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy385940.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
New York |
|
State:
|
|
NY |
| Zip Code: |
|
10029 |
| Conditions: |
|
Pre-diabetes |
| Purpose: |
|
The purpose of this study is to compare the effectiveness of a peer-led community-based
lifestyle intervention, versus usual care, in achieving weight loss and prevention of
diabetes among overweight adults with pre-diabetes in East Harlem.
|
| Study summary: |
|
Weight loss can prevent diabetes and eliminate racial and ethnic disparities in incident
diabetes among overweight adults with pre-diabetes. However, proven effective interventions
have not been sustained or disseminated in community settings. A community-academic
partnership aims to employ community-based participatory research to conduct a randomized
controlled trial to test the effectiveness of a culturally tailored, peer-led diabetes
prevention intervention that promotes weight loss.
People who develop diabetes go through a period when they have "pre-diabetes". In clinical
settings, overweight adults with pre-diabetes who reduce their weight by 5-10% can reduce
their risk of developing diabetes by 55-60%. To date, there are no studies testing the
effectiveness of peer-led, community-based programs in achieving diabetes prevention through
weight loss.
We will identify and enroll 400 overweight (BMI > 25) adults with pre-diabetes in East
Harlem and randomized half into a community-based, peer-led lifestyle education program that
teaches simple ways to lose weight. |
| Criteria: |
|
Inclusion Criteria:
- 18 years of age and older
- Residents of East Harlem with a permanent residence in zip codes 10029, 10035, OR in
the section of 10037 east of Fifth Avenue
- BMI ≥ 25 AND pre-diabetes glucose values, defined as fasting fingerstick glucose of
100-125mg/dl and/or glucose 2 hours after an oral glucose load of 140-199 mg/dl
- Able to communicate verbally to participate in a group education class
- English or Spanish speaking
Exclusion Criteria:
- < 18 years
- Previous diagnosis of diabetes
- BMI <25
- Fingerstick glucoses outside pre-diabetes level ranges
- Currently pregnant
- On medications that may raise or lower blood glucose
- Cognitive or physical impairment that would preclude comprehension of a conversation
and communicating as part of a group (i.e., dementia, deafness, inability to speak)
- Self-reported terminal illness with life expectancy of less than 1 year
- Plans to relocate from New York City within one year of enrollment |
|
|
|
| Study is available at: |
|
Mount Sinai School of Medicine
New York, NY 10029
United States
Primary Contact:
Carol R Horowitz, MD, MPH
Email: carol.horowitz@mountsinai.org
Phone: 212-659-9567
Secondary Contact:
Carol R Horowitz, MD, MPH
Email: carol.horowitz@mountsinai.org
Phone: 212-659-9567 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|